Jin Suk Lee

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Oxidative Stress

Walled Carbon Nanotubes

Top Venues

International journal of molecular sciences

Nanotechnology, science and applications

This page only lists publications with an associated author ORCID identifier.

Publications

Kang Chan Choi, Do Hyun Lee, Ji Won Lee, Jin Suk Lee, Yeon Kyung Lee, Moon Jung Choi, Hwa Yeon Jeong, Min Woo Kim, Chang-Gun Lee, Yong Serk Park
Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells. International journal of molecular sciences 25 (3) (2024)
Kang Chan Choi, Do Hyun Lee, Ji Won Lee, Jin Suk Lee, Yeon Kyung Lee, Moon Jung Choi, Hwa Yeon Jeong, Min Woo Kim, Chang-Gun Lee, Yong Serk Park
Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells. International journal of molecular sciences 25 (3) (2024)
Kang Chan Choi, Do Hyun Lee, Ji Won Lee, Jin Suk Lee, Yeon Kyung Lee, Moon Jung Choi, Hwa Yeon Jeong, Min Woo Kim, Chang-Gun Lee, Yong Serk Park
Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells. International journal of molecular sciences 25 (3) (2024)
Kang Chan Choi, Do Hyun Lee, Ji Won Lee, Jin Suk Lee, Yeon Kyung Lee, Moon Jung Choi, Hwa Yeon Jeong, Min Woo Kim, Chang-Gun Lee, Yong Serk Park
Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells. International journal of molecular sciences 25 (3) (2024)
Kang Chan Choi, Do Hyun Lee, Ji Won Lee, Jin Suk Lee, Yeon Kyung Lee, Moon Jung Choi, Hwa Yeon Jeong, Min Woo Kim, Chang-Gun Lee, Yong Serk Park
Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells. International journal of molecular sciences 25 (3) (2024)
Moon Jung Choi, Kang Chan Choi, Do Hyun Lee, Hwa Yeon Jeong, Seong Jae Kang, Min Woo Kim, In Ho Jeong, Young Myoung You, Jin Suk Lee, Yeon Kyung Lee, Chan Su Im, Yong Serk Park
EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms. Nanotechnology, science and applications 15 (2022)